日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / State Council News

Nation issues new anti-monopoly guidelines for pharma sector

By Li Jiaying | chinadaily.com.cn | Updated: 2025-01-24 21:04
Share
Share - WeChat
Pharmacists dispense drugs at a hospital in Huzhou, Zhejiang province, in August. YI FAN/FOR CHINA DAILY

In an effort to safeguard fair market competition and protect consumer interests, the State Council's anti-monopoly commission officially issued new anti-monopoly guidelines on Friday targeting the pharmaceutical sector. 

A key highlight of the guidelines lies in the involvement of online platforms' monopolistic regulations. Given the rapid growth of online medical consultations and pharmaceutical e-commerce, the guidelines, for the first time, incorporate measures to address monopolistic practices in online medicine businesses, prohibiting platforms from engaging in the misuse of data, algorithms or platform rules.

The broad scope of the new guidelines also merits attention, which encompasses the entire pharmaceutical product chain — including traditional Chinese medicine, chemical drugs and biological products — compared to the previous version, which was largely concentrated in the limited realm of chemical active pharmaceutical ingredients (APIs).

"The pharmaceutical industry is highly technology-driven. Besides APIs, it also includes innovative drugs, patented medicines and generics. Every stage — from procurement and R&D to production, distribution and generic development — involves significant technological advancements and related protective strategies," said Zhou Wei, deputy director of the health law research center at Wuhan University, in an earlier interview. 

To further combat "false innovation", the guidelines also address a new type of patent monopoly behavior known as "product hopping". 

Product hopping refers to a strategy employed by original drug manufacturers to avoid or reduce competition from generic drugs, which mostly occurs shortly before the expiration of a patented drug and the entry of its generic counterpart and if applied inappropriately, could constitute an abuse of market dominance.

Factors for evaluation include whether the new patented drug represents a non-substantial improvement and whether the transition hinders or delays the entry of generics into the market, according to the guidelines.

"This is not about restricting the development of patented drugs but about regulating false innovation that fails to significantly improve a drug's efficacy, safety or utility," Zhou said.

Comprising seven chapters and 55 articles, the guidelines aim to provide detailed interpretations of monopolistic practices, enforcement principles and criteria for determining violations, offering a comprehensive framework to tackle anti-competitive behaviors in the pharmaceutical industry.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 欧美视频精品一区二区三区 | 日本超碰 | 日本又黄又粗暴的gif动态图含羞 | 国产美女被爽到高潮免费A片小说 | 久久亚洲春色中文字幕久久 | 久久精品视 | 婷婷色国产偷v国产偷v小说 | 日韩中文字幕 | 97视频免费播放观看在线视频 | 魔法骑士在线观看免费完整版 | 免费啪视频在线观看免费的 | a级片在线免费播放 | 99精品久久秒播无毒不卡 | 高清国语自产拍免费视频国产 | 嫩草影院免费 | 午夜电影免费看 | 欧美综合自拍亚洲综合图片区 | 国产视频久久 | 嫩草影院在线免费观看 | 午夜黄网| 欧美另类亚洲 | 毛片毛片毛片毛片毛片毛片毛片 | 国产精品影视 | 国产浮力影院在线地址 | 亚洲网视频| 午夜国产精品免费观看 | 日本黄页在线观看 | 久久综合五月开心婷婷深深爱 | 中文字幕精品视频 | 国产在线二区 | 亚洲精品国偷拍自产在线观看 | 日日a.v拍夜夜添久久免费 | 亚洲人性生活视频 | 精品国产成人在线 | 猛龙怪客 | 亚州精品天堂中文字幕 | 看一级毛片国产一级毛片 | 日韩三级伦理在线 | 狠狠干夜夜草 | 国产精品日本欧美一区二区 | 日本高清视频www |